Back
AbbVie Vs. Bristol-Myers Squibb Industry Stock Comparison
Buy
59
ABBV
AbbVie
Last Price:
$187.26
Seasonality Move:
1.68%
Sell
37
BMY
Bristol-Myers Squibb
Last Price:
$47.95
Seasonality Move:
-1.44%
Sell
37
Bristol-Myers Squibb (BMY)
is a Sell
Is Bristol-Myers Squibb a Buy, Sell or Hold?
-
The current Bristol-Myers Squibb [BMY] share price is $47.95. The Score for BMY is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
-
BMY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ABBV Stock Price Chart
BMY Stock Price Chart
What is Bristol-Myers Squibb's stock price today?
-
The Bristol-Myers Squibb share price today is $47.95The current trend is relatively stagnant and BMY is experiencing selling pressure, which indicates risk of future bearish movement.
ABBV Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.33 | Sell |
Relative Strength Index (14 RSI): | 51.99 | Buy |
Chaikin Money Flow: | -4171544 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (182.09 - 191.51) | Buy |
Bollinger Bands (100): | (177.04 - 203.72) | Sell |
BMY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.56 | Sell |
Relative Strength Index (14 RSI): | 47.75 | Sell |
Chaikin Money Flow: | -11203080 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (46.24 - 49.06) | Buy |
Bollinger Bands (100): | (49.2 - 59.62) | Sell |
ABBV Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 185.67 | Buy |
20-day SMA: | 184.99 | Buy |
50-day SMA: | 187.11 | Buy |
200-day SMA: | 188.92 | Sell |
8-day EMA: | 186.04 | Buy |
20-day EMA: | 185.75 | Buy |
50-day EMA: | 187.67 | Sell |
200-day EMA: | 185.77 | Buy |
BMY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 47.71 | Buy |
20-day SMA: | 47.16 | Buy |
50-day SMA: | 50.53 | Sell |
200-day SMA: | 54.16 | Sell |
8-day EMA: | 47.83 | Buy |
20-day EMA: | 47.9 | Buy |
50-day EMA: | 50.15 | Sell |
200-day EMA: | 52.98 | Sell |
AbbVie Earnings Growth & ABBV Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.29 per share, a decrease next quarter of $1.88 per share, an increase this year of $2.07 per share, and an increase next year of $1.71 per share.
Bristol-Myers Squibb Earnings Growth & BMY Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.23 per share, a decrease next quarter of $0.19 per share, an increase this year of $5.90 per share, and a decrease next year of $0.74 per share.
AbbVie Technical Analysis
May 21 | May 22 | May 23 | May 27 | May 28 | May 29 | May 30 | Jun 2 | Jun 3 | Jun 4 | |
---|---|---|---|---|---|---|---|---|---|---|
May | Jun | |||||||||
21 | 22 | 23 | 27 | 28 | 29 | 30 | 02 | 03 | 04 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Bristol-Myers Squibb Technical Analysis
May 21 | May 22 | May 23 | May 27 | May 28 | May 29 | May 30 | Jun 2 | Jun 3 | Jun 4 | |
---|---|---|---|---|---|---|---|---|---|---|
May | Jun | |||||||||
21 | 22 | 23 | 27 | 28 | 29 | 30 | 02 | 03 | 04 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |